Not only are Intel's (NASDAQ:INTC) older chips having trouble with the patches for the Spectre and Meltdown security flaws, but data center computers with its newer chips are also experiencing "higher-than-expected reboot rates."
The company will send out initial versions of fixes for the buggy patches to customers by next week, said Navin Shenoy, general manager of Intel's data center group.
California Representative Jerry McNerney has written to the chief executives of Intel (NASDAQ:INTC), ARM Holdings (NASDAQ:ARMH) and AMD asking them to explain the scope of Spectre and Meltdown, two major security flaws disclosed earlier this month.
The request is one of the first responses from the U.S. Congress to outline the timeframe for understanding the vulnerabilities, how consumers are affected and whether the flaws have been exploited.
The Wall Street Journal reported this morning that Intel (NASDAQ:INTC) sent a letter advising some computer makers and large cloud providers to stop microcode updates related to the chip flaws.
Intel has since clarified that the systems affected by the reboot issue were running Broadwell and Haswell CPUs. The company is working with those customers to diagnose and correct the problem, which isn’t security related.
AMD (NASDAQ:AMD) shares drop following a Yahoo Finance interview with CEO Lisa Su, who acknowledges again that the company’s chips were affected by the Spectre security flaw.
Key quote: “To clarify, for Meltdown, AMD is not susceptible. We don’t have a susceptibility to that variant. But with Spectre, AMD is susceptible.”
As Google outlined in a blog post earlier today, the Spectre flaw comes in two variants Google called Variant 1 and Variant 2 while Meltdown was Variant 3. Variant 2 was the hardest problem to resolve.
Intel (NASDAQ:INTC) posts a “Security-First Pledge” from CEO Brian Krzanich that includes three commitments to customers in the wake of the chip security flaws.
Intel says at least 90% of Intel CPUs released in the past five years will be updated by January 15. Updates will then begin for older products.
Promising better transparency: “We know that the impact on performance varies widely, based on the specific workload, platform configuration, and mitigation technique. We commit to provide frequent progress reports of patch progress, performance data and other information.”
Security assurance: Intel will “publicly identify significant security vulnerabilities following rules of responsible disclosure” and add funding for security threat research.
Cancer diagnostics: Bristol-Myers (NYSE:BMY) co-led a $75M Series B round in Personal Genome Diagnostics (PGDx), a cancer diagnostics startup. New Enterprise Associates also led and was joined by Co-win Healthcare Fund, Helsinn Investment Fund, Inova Strategic Investments, the Maryland Venture Fund, and Windham Venture Partners. The round brings PGDx up to $99.3M in total funding, according to Crunchbase.
PGDx will use the funding to develop an in-vitro diagnostic test kit for easier genomic testing. Labs wanting to use PGDx tests currently have to send samples into the company’s labs in Baltimore. PGDx plans to pursue FDA and international approvals to package the kits for independent labs to use in-house, which would speed up test results and treatment.
Competitors: Genomic Health (NASDAQ:GHDX), Inivata, and Resolution Biosciences.
Biomed data: Microsoft (NASDAQ:MSFT) made an undisclosed strategic investment in biomedical data management company DNAnexus as part of a $58M financing round. Foresite Capital led the round with existing investors include GV (NASDAQ:GOOGL), Claremont Creek, MidCap Financial, TPG Biotech, and WuXi NextCODE. The round brings DNAnexus up to $104.6M in total funding.
DNAnexus developed a platform providing large genomic and biomedical datasets from which companies can gain insights or build and deploy apps. The company has an early access program for Google Brain’s DeepVariant Technology and has a collaboration with AstraZeneca’s (NYSE:AZN) Centre for Genomics Research.
Digital therapeutics: Novartis (NYSE:NVS) was among the investors in a $50M Series B round for prescription digital therapeutics developer Pear Therapeutics. Temasek led the round with other new and returning investors 5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M.
Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical application to help treat substance use disorders.” The app is used in conjunction with outpatient therapy for alcohol, cocaine, marijuana, and stimulant substance abuse disorders but not for opioid treatment.
The company’s pipeline includes reset-O for opioid use, THRIVE for schizophrenia, recall for combat PTSD, and reVIVE for general anxiety disorder, pain, major depressive disorder, and insomnia.
Autonomous vehicle tech: Cisco Investments (NASDAQ:CSCO) and Samsung Catalyst Fund (OTC:SSNNF, OTC:SSNLF) participated in a $38M Series C round for full-stack autonomous vehicle tech company AImotive. B Capital Group and Prime Ventures led the round with other participants including Robert Bosch Venture Capital, Inventure, Draper Associates, and Day One Capital. The round brought AImotive’s total fundraising up to $47.3M.
AImotive provides camera-first, AI-powered autonomous driving tech that uses the cameras to mimic human vision. Products include aiDrive, aiSim, and aiWare, which are also available as a suite for OEMs and mobility players. Current collaborations exist with Groupe PSA, SAIC, and Volvo.
AImotive has offices around the world and is testing self-driving vehicles in Hungary, Finland, and the U.S. states of California and Nevada. Testing in Japan, China, and a U.S. expansion should happen this year.
Competitors: AImotive competes broadly with self-driving vehicle tech leaders Google, Uber (Private:UBER), and Baidu (NASDAQ:BIDU) plus assistive tech providers like Intel’s (NASDAQ:INTC) Mobileye.
Trucking logistics: JD.com (NASDAQ:JD) subsidiary JD Logistics led a $23M Series C round in Chinese trucking logistics startup Fuyoukache, which brings the round total up to $59M and total funding up to $98.2M. Other participants were existing investors Legend Capital, which led the first phase of the round, Eastern Bell Venture Capital, and Global Logistic Properties.
Fuyoukache provides long-distance truck logistic services to enterprises, individuals, and third-party logistics companies. The company operates in 31 provinces in China and has partnerships with more than 30 regional logistics companies.
E-sports streaming: Google (GOOG, GOOGL) joined an undisclosed Series D round in Chinese gaming live-stream company Chushou. Other investors include Qiming Venture, Shunwei Capital, and Alpha X Capital. Chushou said it had raised $120M to date.
Chushou has around 8M streamers and 250K live streams per day. The company plans to use the funding to expand services to include overseas viewers.
Google’s search engine is blocked in China and the tech giant has used investments as a way to broaden its presence in the market. Google took a minority stake in Chinese AI startup Mobvoi in 2015 during a $75M fundraising round.
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Subscription notice: You can automatically receive Stocks to Watch every week by following the SA Stocks to Watch account and setting email alerts on.
A blockbuster week of conferences is on tap to give investors all kinds of fresh data points. Tech heavyweights and startups gather at CES in Las Vegas, where a focus on smart home products powered by Apple (NASDAQ:AAPL) HomeKit and Amazon (NASDAQ:AMZN) Alexa is anticipated. In an interesting bit of timing, Intel (NASDAQ:INTC) CEO Brain Krzanich will deliver the pre-CES keynote address. Meanwhile, all eyes in the retail sector will be focused on the ICR Conference in Orlando, with plenty of guidance updates expected. There's also the JPMorgan Healthcare conference in San Francisco which is sure to turn heads. Seeking Alpha will be posting all the breaking news from each conference. Check out #CES18, #ICR18, #JPM18 all week for the latest updates.
CES: The tech industry's biggest confab runs from Tuesday to Friday. Speakers include Ford (NYSE:F) CEO Jim Hackett, Verizon CTO (NYSE:VZ) Hans Vestberg, Qualcomm (NASDAQ:QCOM) President Christiano Amon, YouTube's (GOOG, GOOGL) Robert Kyncl and Baidu COO (NASDAQ:BIDU) Qi Lu. On the floor, exhibitions on artificial intelligence potential, augmented reality, 4K TVs, robots and new drones will be just part of the buzz.
ICR conference: More than 150 companies are scheduled to make presentations following the strong holiday season. Wildcards that could be discussed by management include the impact of U.S. tax reform and the impact from the unusually cold weather spell over the last few weeks. The list of retailers giving updates includes Crocs (NASDAQ:CROX), Urban Outfitters (NASDAQ:URBN), Lululemon (NASDAQ:LULU), Wayfair (NYSE:W), Shake Shack (NYSE:SHAK), L Brands (NYSE:LB), Domino's Pizza (NYSE:DPZ), Jack in the Box (NASDAQ:JACK), Dunkin' Brands (NASDAQ:DNKN), SodaStream (NASDAQ:SODA), Five Below (NASDAQ:FIVE) and Darden Restaurants (NYSE:DRI).
Expected IPO filings: Nebula Acquisition Corp. (NEBUU) and Muscle Maker (MMB) on Jan. 10; Liberty Oilfield Service (OTC:LBRT) and Industrial Logistics Properties (Pending:ILPT) on Jan 12.
Analyst quiet period expiration: Newmark (NASDAQ:NMRK) and CASA Systems (Pending:CASA) on Jan. 9.
IPO/secondary share lockup period expirations: KNOT Offshore Partners (NYSE:KNOP) and Co-Diagnostics (Pending:CODX) on Jan. 8; Eagle Bancorp Montana (NASDAQ:EBMT), Akcea Therapeutics (NASDAQ:AKCA), MYnd Analytics (MYND), Flexion Therapeutics (NASDAQ:FLXN), Eiger BioPharmaceuticals (NASDAQ:EIGR) and Protagonist Therapeutics (NASDAQ:PTGX) on Jan. 10; REV Group (NYSE:REVG), Tandem Diabetes Care (NASDAQ:TNDM), CatchMark Timber Trust (NYSE:CTT), BioTime (NYSEMKT:BTX) and AnaptysBio (NASDAQ:ANAB) on Jan. 11.
JPMorgan Healthcare Conference: Presenters for the event running from Jan. 8-11 include Vertex Pharmaceuticals (NASDAQ:VRTX), Jazz Pharmaceuticals (NASDAQ:JAZZ), Alexion Pharmaceuticals (NASDAQ:ALXN), Sarepta Therapeutics (SPT), Regeron (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Gilead Sciences (NASDAQ:GILD), Sage Therapeutics (NASDAQ:SAGE) and Incyte (NASDAQ:INCY). Based on prior years, updates could come in from Haolozyme Therapeutics (NASDAQ:HALO), NuVasive (NASDAQ:NUVA), Acorda Therapeutics (NASDAQ:ACOR), Celgene (NASDAQ:CELG) and a host of others. Microsoft (NASDAQ:MSFT) founder Bill Gates will give a keynote address.
Sales reports/updates: Five Below (FIVE), Haverty (NYSE:HVT) and Kohl's (NYSE:KSS) on Jan. 8; Target (NYSE:TGT) on Jan. 9; Signet Jewelers (NYSE:SIG) on Jan. 10; GameStop (NYSE:GME) on Jan. 12.
Investor/Analyst Day: Domino's Pizza (DPZ) on Jan. 10.
Shareholder M&A vote: Bob Evans Farms (NASDAQ:BOBE) on Jan. 9.
Barron's mentions: FedEx (NYSE:FDX) is tagged as a stock that could run up a 20% gain as capex investments pay off on the bottom line for the shipper. Despite a strong rally in 2017 for the Macau sector, more upside is seen for Wynn Resorts (NASDAQ:WYNN), Melco Resorts & Entertainment (NASDAQ:MLCO), Las Vegas Sands (NYSE:LVS) and to a lesser extent MGM Resorts (NYSE:MGM). It's time to lighten up exposure to FAANG (FB, AMZN, NFLX) stocks after a 49% gain in 2017, warns the publication.
Qualcomm (NASDAQ:QCOM) has confirmed that its processors are affected by recent exploits, according to The Register.
"So kind of @Qualcomm to confirm at 2.30pm PT on a Friday that its processors are affected by Meltdown and Spectre, too," the publication just tweeted.
Shares have turned down in aftermarket trading, -0.7%.
The news comes a day after acknowledgment by Apple that all its devices are subject to the processor exploits. After a couple of days of losses, Intel (NASDAQ:INTC) closed higher today by 0.7%; and AMD lost ground after a couple of strong days, finishing 2% lower.
The Intel (NASDAQ:INTC) chip issues have only slowed computers slightly, according to impacted tech giants, and security researchers have backed off the need for hardware replacements.
Intel says Apple, Amazon, Google, and Microsoft all reported little to no performance impact from the required security patches.
Microsoft and Google separately say they expect few performance issues for cloud computing customers. Apple also independently confirmed that its tests showed no significant processing speed impact from the patches.
Carnegie Mellon’s cybersecurity project CERT withdraws recommending CPU replacement for an affected system. CERT now says that “operating system and some application updates mitigate these attacks.”
Intel shares are up 0.2% premarket.
Shares of competitor AMD (NASDAQ:AMD) are up 1.7%.
Apple (NASDAQ:AAPL) is confirming tonight that its devices are affected by the much-discussed "Spectre" and "Meltdown" processor exploits, whose revelation has depressed Intel (NASDAQ:INTC) stock for two days and given a boost to AMD.
"All Mac systems and iOS devices are affected, but there are no known exploits impacting customers at this time," the company says in a forum post. "Since exploiting many of these issues requires a malicious app to be loaded on your Mac or iOS device, we recommend downloading software only from trusted sources such as the App Store."
The company plans mitigations "in the coming days" for Safari, to defend against Spectre, and says it's already released mitigations in iOS 11.2, macOS 10.13.2, and tvOS 11.2 to help defend against Meltdown.
Apple Watch isn't affected by Meltdown, the company says.
Apple shares are up 0.1% in after-hours action. INTC fell another 1.8% today and is down 0.3% in postmarket trading; AMD rose another 4.9% today and is up 0.6% after hours.